This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Annabelle Fowler is a panelist on “Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking” and we discuss the current state of M&A activity in the biopharma space, as well as what projections for dealmaking activity will look like in the year ahead.
CRA is also a proud sponsor of the conference.
For more information on this event, click here.
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...
CRA’s Annabelle Fowler, Andreas Maos, and Tim Wilsdon co-authored original research that explores the roles and contributions of public and private investments...
